Reports from last week that the German vaccine commission will only recommend licensing the #AstraZeneca vaccine for use for under 65 year olds have now been confirmed.
As expected they cite a lack of data that put doubts on the efficiency in that age group. (8% as per last week)
As expected they cite a lack of data that put doubts on the efficiency in that age group. (8% as per last week)
I was attacked last week for tweeting about this. There were also a lot of anti German comments and anti EU comments, suggesting this was done in spite.
Their decision is very much based on data, after a thorough analysis during their approval process.
This is not fake news!
Their decision is very much based on data, after a thorough analysis during their approval process.
This is not fake news!
The AZ trials included only 8% of people between 56-69 years old and an even lower 4% of people above 70 years old.
There is not enough evidence of efficiency & risks/side effects in the view of the German vaccine commission to justify recommending use in the 65+ age group.
There is not enough evidence of efficiency & risks/side effects in the view of the German vaccine commission to justify recommending use in the 65+ age group.
They are actually disappointed about this, because it puts their planned role out of the vaccination programme (a mix of different vaccines), especially in the higher age and higher risk groups further at risk and is causing additional delays.
It's not good news sadly.
It's not good news sadly.
And if you trust an English article more than a German one, or don't fancy translating it, here's an English one:
bloomberg.com/news/articles/…
bloomberg.com/news/articles/…
Seeing that people keep accusing me of lying, here's an additional table the German agency used.
You can see the low number of participants in older age groups with 1 case each in vaccinated/control group and hence a calculated efficiency of 6.3% only.
Limited data = no license.
You can see the low number of participants in older age groups with 1 case each in vaccinated/control group and hence a calculated efficiency of 6.3% only.
Limited data = no license.
I have also seen UK MSM push reports such as this. 🤷♀️
They don't claim it is unsafe.
They say the trial included too low a number of participants aged 65+ to have reliable data.
AstraZeneca Vaccine: UK Dismisses Claim Covid Jab Is Unsafe For Over-65s
huffingtonpost.co.uk/entry/germany-…
They don't claim it is unsafe.
They say the trial included too low a number of participants aged 65+ to have reliable data.
AstraZeneca Vaccine: UK Dismisses Claim Covid Jab Is Unsafe For Over-65s
huffingtonpost.co.uk/entry/germany-…
And because they don't have enough data to show if it works enough or not, and if there's heightened risks or side effects or not for that age group, they don't recommend to license it.
They'll review once more data becomes available.
It's a data based decision.
It's not a lie.
They'll review once more data becomes available.
It's a data based decision.
It's not a lie.
That's what a thorough approval process does.
They looked at all the data and evidence and lack of evidence and then made an informed decision.
If AstraZeneca would have done proper tests across all age groups (especially 65+ as higher risk) this would not have happened. 🤷♀️
They looked at all the data and evidence and lack of evidence and then made an informed decision.
If AstraZeneca would have done proper tests across all age groups (especially 65+ as higher risk) this would not have happened. 🤷♀️
• • •
Missing some Tweet in this thread? You can try to
force a refresh
